U.S. House · 117th Congress · H.R. 8289
Banning Misleading Drug Ads Act of 2022
To require the Secretary of Health and Human Services to promulgate a past due final rule with respect to direct-to-consumer prescription drug advertisements, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Abigail Davis SpanbergerD-VA-7
- Introduced
- July 5, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (5)
5 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Cynthia AxneD-IA-3
- Angie CraigD-MN-2
- Katie PorterD-CA-45
- Susan WildD-PA-7
Signed on later
- Eleanor Holmes NortonD-DC-ALOctober 31, 2022